AvePoint, Inc.
$17.09-$0.26 (-1.5%)
AvePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.45% below the high.
NYSE · ETWO · USD
Stock price, earnings
Quote as of Aug 1, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
E2open Parent Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 28.73% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow E2open Parent Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
E2open Parent Holdings, Inc. delivers a comprehensive, cloud-native Software-as-a-Service (SaaS) solution for managing supply chains, with operations spanning the Americas, Europe, and the Asia Pacific. The company's proprietary software is designed to streamline intricate supply chain processes, generating substantial value and a strong return on investment for its esteemed corporate clientele. This robust platform seamlessly integrates diverse networks, critical data, and various applications, furnishing clients with the tools to fine-tune every aspect of their supply chain. This optimization encompasses key areas such as channel strategy, demand forecasting, business planning, global trade compliance, logistics and transportation, collaborative manufacturing, and procurement oversight. E2open serves a broad spectrum of industries, including technology, consumer goods, industrial manufacturing, and transportation. Established in 2020, the company maintains its primary offices in Austin, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $158.45M+1.97% vs estimate |
| Q3 2024 | Jan 9, 2024 | $0.04-5.88% vs estimate | $157.50M+2.03% vs estimate |
|---|
| Q2 2024 | Oct 10, 2023 | $0.04-20.0% vs estimate | $158.49M-0.73% vs estimate |
|---|
THE ANALYST VIEW
10 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$17.09-$0.26 (-1.5%)
AvePoint, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.45% below the high.
$12.15-$0.13 (-1.06%)
Cellebrite DI Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.19% below the high.
$51.93-$6.86 (-11.67%)
Penguin Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.21% below the high.
$13.96+$0.01 (+0.07%)
WalkMe Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
$30.00+$0.03 (+0.1%)
Model N, Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.15% below the high.
$10.76-$0.04 (-0.37%)
Enfusion, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.81% below the high.
$85.90+$0.65 (+0.76%)
MoneyLion Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.58% below the high.
$14.50+$0.39 (+2.76%)
Verb Technology Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.29% below the high.